Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting
  • Home
  • Signaling Pathways

Signaling Pathways

9 Items

per page
  1. MDL 28170
    A4412 MDL 28170
    Target: Cathepsins|Calpains
    Summary: Calpain and cathepsin B inhibitor, selective
      insoluble in H2O; ≥16.75 mg/mL
  2. SID 26681509
    A4424 SID 26681509
    Target: Cathepsins
    Summary: Human cathepsin L inhibitor,potent and reversible
      <26.98 mg/mL
  3. CA-074 Me
    A8239 CA-074 Me
     7 Citation
    Target: Cathepsins
    Summary: Cathepsin B inhibitor
      insoluble in H2O; ≥19.88 mg/mL
  4. Odanacatib (MK-0822)
    A2487 Odanacatib (MK-0822)
    Target: Cathepsins
    Summary: Cathepsin K,potent and selective
      insoluble in EtOH; insoluble in H2O; ≥17.7 mg/mL
  5. E-64
    A2576 E-64
     2 Citation
    Target: Cathepsins|Calpains|Papains
    Summary: Cysteine protease inhibitor,irriversible
      ≥49.1 mg/mL
  6. E 64d
    A1903 E 64d
     4 Citation
    Summary: Cysteine protease inhibitor
      insoluble in H2O; ≥17.12 mg/mL
  7. CA 074
    A1926 CA 074
     2 Citation
    Target: Cathepsins
    Summary: Cathepsin B inhibitor
      ≥19.17 mg/mL
  8. E-64-c
    A8162 E-64-c
    Target: cysteine protease
    Summary: Inhibitor of cysteine proteinases
      ≥31.4 mg/mL
  9. Cathepsin S inhibitor
    A3284 Cathepsin S inhibitor
     1 Citation
    Target: Cathepsins
    Summary: Blocks MHCII antigen presentation
      ≥24.25 mg/mL

9 Items

per page